T cell revival through PD-1: Clues for cancer immunotherapy
Cancer immunotherapy drugs that block the inhibitory PD-1 pathway have shown success in clinical trials and are now FDA-approved for melanoma, lung cancer and bladder cancer. Yet many patients' tumors do not respond to these ...
Aug 2, 2016
0
123